Select a Month...
Latest Press Releases
Seattle Children’s Commits to Rigorous Review of Race, Equity and Inclusion Practices
New board committee formed, will include community members and independent outside expert
Seattle Children’s Plans COVID-19 Vaccine Rollout
Today, Seattle Children’s received its first doses of Pfizer’s COVID-19 vaccine and will deploy its allocation in phases based on guidelines from the Centers...
Statement from Seattle Children’s on Main Campus Operating Rooms
We frequently test the air in every OR and can confirm the operating rooms at Seattle Children’s are safe.
GentiBio launches to develop engineered regulatory T cells for autoimmune and inflammatory diseases
Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children's Research Institute, Benaroya...
CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases – Wiskott-Aldrich...
Seattle Children’s Research Institute: Building Cure Opens in Downtown Seattle to Accelerate Pediatric Research Discoveries
New building expands Seattle Children’s research campus to over 1.1 million square feet
Seattle Children’s Receives $20 Million Gift From Ballmer Family to Support Odessa Brown Children’s Clinic
Gift brings total raised for OBCC to nearly $90 million; Seattle Children’s aims to raise $125 million by 2021
UW Medicine and Seattle Children’s Appoint New Department of Pediatrics Chair, Associate Dean and Senior Vice President, Chief Academic Officer
Dr. Leslie R. Walker-Harding to assume position in February 2019
Seattle Children’s Opens New Clinic to Better Serve Families in North King, Snohomish, Whatcom and Skagit Counties
The new clinic will provide access to more than 18 pediatric specialty care services in the North Sound region
Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial
Open to children and young adults with relapsed or refractory disease, clinical trial extends immunotherapy to several types of EGFR-expressing solid tumors